Mohammad Khaja NazeeruddinDr. Md. K. Nazeeruddin received M.Sc. and Ph. D. in inorganic chemistry from Osmania University, Hyderabad, India. He joined as a Lecturer in Deccan College of Engineering and Technology, Osmania University in 1986, and subsequently, moved to Central Salt and Marine Chemicals Research Institute, Bhavnagar, as a Research Associate. He was awarded the Government of Indias fellowship in 1987 for study abroad. In 2014, EPFL awarded him the title of Professor. His current research at EPFL focuses on Dye Sensitized Solar Cells, Perovskite Solar Cells, CO2 reduction, Hydrogen production, and Light-emitting diodes. He has published more than 509 peer-reviewed papers, ten book chapters, and he is inventor/co-inventor of over 50 patents. The high impact of his work has been recognized by invitations to speak at over 130 international conferences, and has been nominated to the OLLA International Scientific Advisory Board. He appeared in the ISI listing of most cited chemists, and has more than 49'000 citations with an h-index of 105. He is teaching "Functional Materials" course at EPFL, and Korea University; directing, and managing several industrial, national, and European Union projects. He was awarded EPFL Excellence prize in 1998 and 2006, Brazilian FAPESP Fellowship in 1999, Japanese Government Science & Technology Agency Fellowship, in 1998, Government of India National Fellowship in 1987-1988. Recently he has been appointed as World Class University (WCU) professor by the Korea University, Jochiwon, Korea (http://dses.korea.ac.kr/eng/sub01_06_2.htm), Adjunct Professor by the King Abdulaziz University, Jeddah, Saudi Arabia and Eminent Professor in Brunei. Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Stewart ColeProfessor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.
Cristina Ramona Cudalbu MoldovanCristina Cudalbu obtained her Bachelors of Science degree in Medical Physics in 2002 and Masters of Science degree in Biophysics and Medical Physics in 2003, both from University Babes-Bolyai, Cluj-Napoca, Romania. In 2006 she obtained her PhD degree in Localized Proton MRS and time domain quantification of cerebral metabolites at 7T and 4.7T at University Lyon 1, RMN Laboratory, Villeurbanne, France.In 2007, she joined, as a Scientist, the Laboratory for Functional and Metabolic Imaging at EPFL, where she implemented new acquisition and quantification techniques for in vivo nitrogen, proton and carbon MRS for preclinical studies. Starting 2012, Cristina Cudalbu was appointed as Research Staff Scientist and 9.4T MRI Operational Manager at Centre d’Imagerie Biomédicale (CIBM) at EPFL. She is now developing new research lines at CIBM, being oriented towards new acquisition and quantification techniques for in vivo proton, phosphorous, carbon, nitrogen MRS and fast MRSI, diffusion weighted spectroscopy and brain macromolecules quantification. She is now applying these developments on chronic hepatic encephalopathy, a research area that she developed at CIBM (https://actu.epfl.ch/news/when-liver-disease-affects-the-brain/), and on different collaborative projects with researchers from the five partner institutions of CIBM. Ianina AltshulerTeaching & PhD PhD Students Haohua He, Anna Dukat, Laureen Sarah Ahlers, Anastasiia Kosolapova, Grace Emma Marsh Courses Biology ENV-103 This course will cover the fundamental principles governing life and the living world. Topics will include the diversity of living organisms, cellular biology, genetics, evolution, and ecology. This course provides a foundation in biology, fostering critical thinking & analytical skills. EESS - CESS Seminar Course - option 1 (FALL) ENV-630(a)
Rolf GruetterAwards:
1999 Young Investigator Award Plenary Lectureship
, International Society for Neurochemistry
2011 Fellow
, ESMRMB
2011 Teaching Award
, Section Sciences de la Vie, EPFL
Gabor LaurenczyTeaching & PhD Past EPFL PhD Students Christian Ohlin, Céline Fellay, Weijia Gan, Katerina Stefania Sordakis, Mickael Montandon-Clerc, Cornel Fink, Lu Chen Past EPFL PhD Students as codirector Séverine Joëlle Moret, Felix Daniel Bobbink
Christian Ludwig2005 - today: Adjunct Professor at EPFL in the field of Solid Waste Treatment and head of the Chemical Processes and Materials research group (CPM) at Paul Scherrer Institute (PSI). Joint EPFL-PSI Professorship on Solid Waste Treatment. 2000 - today: Head, Group of Chemical Processes and Materials (CPM) at Paul Scherrer Institut (PSI). In 2009 the LEM unit was closed and the CPM group is now affiliated to the Bioenergy and Catalysis Laboratory (LBK) of the Energy and Environment Research Division (ENE). Since June 2002 permanent position ("tenure"). 1997 - 1999: Senior Scientist. Paul Scherrer Institut (PSI), General Energy Research Department, Element Cycles Section. 1995 - 1997: Research Fellow. Swiss Federal Institute for Environmental Science and Technology (EAWAG), Department of Resource and Waste Management. 1993 - 1995: Post-doc Fellow. University of California Davis, Department of Land, Air, and Water Resources (LAWR). 1990 - 1993: PhD Student. University of Berne, Department of Inorganic, Analytical, and Physical Chemistry. 1989 - 1990: Master Student. University of Berne, Department of Inorganic, Analytical, and Physical Chemistry.
Georges WagnièresGeorges Wagnières received his diploma degree (MSc) in physics from the University of Lausanne, Switzerland, in 1986. He obtained his doctorate in science (PhD) in physics (Biomedical optics) from the Swiss Federal Institute of Technology at Lausanne (EPFL) in 1992 and did a postdoctoral work in the Wellman Laboratories of Photomedicine (Harvard Medical School), Boston, USA, from 1993 to 1994. He also obtained a Master degree in Management of Technology delivered by the Ecole des Hautes Etudes Commerciales (HEC) of Lausanne University and the EPFL in 2001. Georges Wagnières manages a research group active in the fields of: - Detection of early superficial cancers by fluorescence imaging. - Characterization of early superficial cancers by high magnification narrow band imaging. - In vivo and in vitro measurement of the vascular and tissular oxygen concentration by time-resolved luminescence spectroscopy and imaging. - Preclinical and clinical study of new photosensitizers for photodynamic therapy (PDT). - Treatment of neurodegenerative conditions (Alzheimer, Parkinson's diseases) by photobiomodulation. - Preclinical and clinical photodynamic therapy of inflammatory bowel diseases and atheroscerotic plaque. - Improvement of the selective vascular extravasation of chemotherapeutic agents by PDT. - Monitoring the light dosimetry during PDT by fluorescence spectroscopy and imaging. - Monitoring laser treatments of the retina by reflectance imaging. - Light dosimetry and tissue optical spectroscopy. - Radiometry. - Development of light delivery systems for biomedical applications. Georges Wagnières is also co-founder and was chairman of one spin-off companies: - Medlight SA, founded in July 1997, which develops, produces and commercializes light distributors for photodynamic therapy. Georges Wagnières has currently authored more than 235 papers (more than 150 in international journals with review board) and is inventor of 18 patents. He supervised 12 PhD students up to now, and currently teaches biomedical optics and photomedicine in master programs and doctoral schools. In addition, he gives the course entitled "Physique Générale I" to biology first year students registered to the Biology School of the Lausanne's University. MAIN PUBLICATIONS Please visit: https://www.epfl.ch/labs/lifmet/wagnieres/publications/ Nikolaos StergiopoulosEducation
MTE, Managing the Technology Enterprise Program (2000), IMD, Lausanne
Ph.D. in Biomedical Engineering & Engineering Mechanics (1990) Iowa State University, Ames, Iowa.
MS in Biomedical Engineering (1987) Iowa State University, Ames, Iowa.
Diploma in Mechanical Engineering (1985) National Technical University of Athens.
Professional Activities
2002 - present: Professor and director of LHTC
2010 - present: Founder and director of Rheon Medical SA, Préverenges, Switzerland
2008 - present: Founder and director of Antlia S.A., PSE-C, EPFL campus, Switzerland
1998 - 2007: Founder and Scientific Director of EndoArt S.A., Lausanne, Switzerland
1996 - 2002: Assistant professor at the Biomedical Engineering Laboratory, Swiss Federal Institute of Technology, Lausanne, Switzerland.
1991 - 1996: Research Associate at Swiss Federal Institute of Technology - Lausanne
1990 - 1991: Lecturer, Iowa State University
Esther AmstadEsther Amstad studied material science at ETH in Zurich. She also carried out her PhD thesis at the same University under the supervision of Prof. Marcus Textor; for her thesis, she worked on the surface modification and steric stabilization of oxide nanoparticles. As a postdoctoral fellow, she joined the experimental condensed soft matter group of David A. Weitz at Harvard University where she used droplet based microfluidics to assemble different types of functional micro- and nanomaterials. In addition, she developped new microfluidic devices that enable the production of very small, airborne drops as well as devices that produce highly monodisperse emulsion drops at a very high throughput. In June 2014, Esther joined the material science department (IMX) of EPFL where she is leading the Soft Materials Laboratory (SMAL).
Mathilde Stéphanie WilleminExpertise
Dynamic and enthusiastic biochemist with a phD in microbiology. Happy to help you realize your project from experimental design to data analysis.
César PulgarinProf. C. Pulgarin is Chemist from Lausanne University, Master in environmental chemistry from Geneva University, Ph D in synthesis bio-inspired of natural substances from Neuchâtel University. During his education he carried out several industrial trainings.
Since March 1989, he has been working at the EPFL where he is leader of the Advanced Oxidation Processes Group (GPAO) active in the development chemical, photochemical, electrochemical, ultrasonic processes, their coupling between them and with biological systems to degrade chemical and microbiological pollutants in water and air. He has an H index of 40 and he is the world most cited author in 1) TiO2 photo-assisted bacterial inactivation in water and 2) Coupling of photochemical and biological processes for pollutant degradation. He has been involved in ten African, South American and European international research projects. He has been Swiss representative in COST program 540.
Rudolf HoviusExpertise
•Protein structure, expression & purification•Molecular interaction & receptor activation•Fluorescence imaging & spectroscopySignalling & sensing
Mission
=> Teaching: Lecture courses, tutorials and practicals in biochemistry, biophysical chemistry of membranes and signalling processes. Participating to the Commission d'Enseignement and Commission de l'Ecole Doctorale of Chemistry and Chemical Engineering.=> Research interests: Protein function and structure, Membrane protein (especially recepto
